Why Mind-Altering Drugs Can Make You Feel Better Fast
- John Makohen
- 4 days ago
- 4 min read
Updated: 3 days ago
May 18, 2026
John Makohen, Author
Tom O'Connor, Publisher
Scientists are chasing the brain change of mind-altering drugs, not only the experience.
You know the feeling. Your brain will not shut up. Your mood stays heavy. Anxiety sits in your chest.
A craving talks like a command. Then a drug hits the system, and the pressure drops fast. So here is the real question. Why can a mind-altering drug make someone feel better, sometimes after one dose?
A growing line of research points to one core idea. The brain changes.Not only during the experience. After the experience.
That matters for depression, trauma, and substance use recovery. It changes how we think about relief and real change.
The first clue came from ketamine.
In 2000, researchers reported rapid antidepressant effects from a low-dose ketamine infusion compared with a placebo. The results showed robust decreases in depressive symptoms. The timing raised eyebrows. The acute drug effects fade. Mood benefits can last longer.
That pushes a hard question. What lasts after the drug leaves?
A second clue came from psilocybin.
Johns Hopkins researchers published work showing that psilocybin, when administered under supportive conditions, could elicit experiences that many participants rated as among the most personally meaningful, with sustained positive changes reported later.
That points to another possible driver. Experience can matter. Meaning can matter. People do not walk away only with a memory. Many report changes that stick.
So what is doing the work? Experience. Biology. Both.
The brain change angle: dendrites, spines, and plasticity
The brain is not static. Neurons form connections. Those connections can strengthen or weaken.
One way scientists study this is by looking at dendritic spines. These tiny structures help neurons connect and communicate. More spines can mean more potential connections and learning capacity.
Stress and depression are linked with reduced synaptic connections in key circuits, including the prefrontal cortex. Researchers have connected ketamine's rapid effects to synaptic and circuit mechanisms.
So the working idea looks like this. Some drugs may open a window for neural growth and reconnection. That window may relate to symptom relief that outlasts intoxication.
Psychedelics and structural plasticity
In 2018, a team led by C. Ly reported that serotonergic psychedelics can increase neuritogenesis and spinogenesis in vitro and in vivo. The paper describes robust increases in structural plasticity, along with related functional effects.
This matters for a simple reason. If a compound increases the brain's capacity to form new connections, it may support new learning. New learning is the base layer for behavior change. If you work in recovery, you already know this part. Relief is not recovery. Relief can create space for recovery.
Space is not the same thing as skill. Skill still takes reps.
The tension in the field.
One camp sees the subjective experience as central. The experience is the therapy. Another camp focuses on structural change. The brain change is the therapy. Both camps have real points.
Some studies link outcomes to the intensity or meaning of the psychedelic experience. The 2006 and 2008 Johns Hopkins papers include data on "mystical type" experiences and later attribution of personal meaning. At the same time, the findings of structural plasticity point to mechanisms that do not depend solely on belief or narrative.
So the practical question becomes this. Can you keep the brain benefits without the trip?
The goal: separate hallucinations from plasticity
Some researchers are designing compounds that promote neuroplasticity without causing hallucinations. This is not a vibe. It is drug development.
Delix Therapeutics has described zalsupindole as a non-hallucinogenic neuroplastogen and reported work focused on biomarkers of neuroplasticity, safety, and preliminary efficacy in major depressive disorder.
Preclinical work on zalsupindole has been published in ACS Chemical Neuroscience, describing pharmacology and efficacy and framing it as a nondissociative, nonhallucinogenic neuroplastogen. This is the bigger move. Build a compound that supports brain adaptation. Remove the sensory distortion.
Early human signals and the right mindset.
Delix reported results from a small study of eighteen adult patients with major depressive disorder receiving zalsupindole on a short schedule. The company described the study goals as biomarker-focused, with preliminary measures of efficacy and safety.
Small early studies can be encouraging yet incomplete. That is the right posture. Interest and caution at the same time. If you care about mental health and addiction treatment, you want rigor. You want controlled trials. You want replication.
Read:
Why this matters for substance use recovery
People use substances for relief. Relief from:
Panic.
Traumatic stress.
Shame.
Insomnia.
Grief.
A brain that will not stop attacking them.
The brain learns quickly. That learning becomes a pattern. Pattern becomes automatic. Automatic becomes hard to interrupt. So a treatment that promotes adaptive plasticity can matter in two ways. It can reduce symptoms that drive use.
It can increase capacity for new learning and new habits. Still, no molecule can do the whole job. A more flexible brain is not the same thing as a changed life.
If you get a window where change feels possible, you still need training inside that window. That is the part people miss.
What do you do with the window?
If you want the brain change to translate into recovery, you need intentional behavior change.
Pick a simple structure. Trigger>Thought>Feeling>Urge>Action
Then practice a different action when the chain starts.
Eat food. Text support. Leave the room. Take a walk. Go to bed. Write the thought down and label it. If you have lived with substance use disorder, you already know this truth.
Relief is a start.
Recovery is repetition.
I learned it the hard way. During my heroin and homelessness years, I could promise change and mean it. Then stress hit, and my brain chased relief as if it were a matter of survival. A new treatment that reduces suffering can help, yet the day-to-day work still decides the outcome.
So keep your eye on what matters.
Brain change can open the door.
Your daily actions decide if you walk through it.
Read John Makohen's bio in the link at the top of this article beside his photo.
If you enjoyed this article,
Please forward this to a friend or colleague who might benefit from it!
Comments